Skip to main content
Back to feed
HealthReportedMediumDeveloping
6.3

Oxford Ebola vaccine enters Phase Ib trials in Uganda amid DR Congo outbreak

Phase Ib trials for the ChAdOx1 Ebola vaccine began in Uganda on Oct. 6, as DR Congo battles an ongoing outbreak. The trial's timing and location suggest a strategic response to regional spread risk, though efficacy and deployment timelines remain uncertain. This development matters as it could provide a new tool to contain outbreaks in high-risk areas.

Anadolu Agency ENabout 12 hours agoUG, CDengCredibility 51%View source

Score Breakdown

Mosaic Score6.3
Model confidence0.7
Significance0.5
Source credibility0.5

Intelligence Tags

#ebola#vaccine#clinical-trial#outbreak#public-health

Locations

UgandaDR Congo
Source

Related signals

8 found